# Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT

> **NCT05708859** · PHASE4 · RECRUITING · sponsor: **Matthew J. Budoff** · enrollment: 120 (estimated)

## Conditions studied

- Type II Diabetes
- Atherosclerosis

## Interventions

- **DRUG:** Tirzepatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05708859
- **Lead sponsor:** Matthew J. Budoff
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-02
- **Primary completion:** 2025-12
- **Final completion:** 2026-05
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05708859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05708859, "Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05708859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*